Yian Du

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 414 citations

D2 Gastrectomy, Surgical Oncology, Esophageal Cancer +10

Knockdown of Long Non-coding RNA HOTAIR Suppresses Tumor Invasion and Reverses Epithelial-mesenchymal Transition in Gastric Cancer

Zhiyuan Xu, Qi Yu, Yian Du et al. · International Journal of Biological Sciences · 2013 · 239 citations · Full text

5-Fluorouracil Chemotherapy of Gastric Cancer Generates Residual Cells with Properties of Cancer Stem Cells

Zhiyuan Xu, Jianing Tang, Huaxia Xie et al. · International Journal of Biological Sciences · 2015 · 111 citations · Full text

Solid Pseudopapillary Neoplasms of the Pancreas: a 19-Year Multicenter Experience in China

Pengfei Yu, Xiangdong Cheng, Yian Du et al. · Journal of Gastrointestinal Surgery · 2015 · 67 citations

Pancreatic Cancer, Pancreatic Fluid Collection, Solid Pseudopapillary Neoplasms +5

Efficient plasma metabolic fingerprinting as a novel tool for diagnosis and prognosis of gastric cancer: a large-scale, multicentre study

Zhiyuan Xu, Yida Huang, Can Hu et al. · Gut · 2023 · 66 citations · Full text